Seattle Genetics, Astellas announce Clinical Trial collaboration with Merck

Clinical Research |  News | 0 Comment | 03 Dec, 2019

Seattle Genetics, Inc. and Astellas Pharma Inc.have announced a clinical collaboration agreement with Merck, known as MSD outside the United States and Canada through a subsidiary...Read more

Combination of Immunotherapy and VEGF Inhibitor Improves Survival in HCC

Clinical Research |  News | 0 Comment | 22 Nov, 2019

Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves overall survival and progression-free survival in patients with unresecta...Read more

Trastuzumab Biosimilar HLX02 Met Primary Endpoint in Breast Cancer

Clinical Research |  News | 0 Comment | 22 Nov, 2019

The trastuzumab biosimilar HLX02 achieved similar overall response rate to reference trastuzumab in women with human epidermal growth factor receptor 2-positive (HER2+) recurrent or previou...Read more

CStone announces first patient dosed in the Phase I study of ivosidenib

Clinical Research |  News | 0 Comment | 20 Nov, 2019

CStone Pharmaceuticals on 20 Nov 2019 announced that the first patient has been dosed in Phase I bridging the registrational study of ivosidenib (TIBSOVO®) in China. This stand-alo...Read more

Roxadustat Phase III study shows positive efficacy in patients with anaemia from CKD

Clinical Research |  News | 0 Comment | 11 Nov, 2019

AstraZeneca and FibroGen Inc. (FibroGen) have presented pooled efficacy and cardiovascular (CV) safety analyses from the pivotal Phase III programme assessing roxadustat for the treatment o...Read more

World first clinical trial commences in alcohol use disorder

Clinical Research |  News | 0 Comment | 28 Oct, 2019

A medication currently used to treat insomnia may also be effective in preventing alcohol intake and relapse in alcohol use disorder, according to researchers at the Florey Institute of Neu...Read more

SCRI honors Clinical Research Coordinators by Distinguished Contributor Award 2019

Clinical Research |  News | 0 Comment | 22 Oct, 2019

The Singapore Clinical Research Institute (SCRI), on 22 Oct 2019, announce the nine winners of the inaugural Distinguished Contributor Award for Clinical Research Coordinators (CRCs). The a...Read more

ASLAN enrolls first patient to study ASLAN004 targeting Atopic Dermatitis

Clinical Research |  News | 0 Comment | 22 Oct, 2019

ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused biopharma company, announced on 22 Oct 2019, the enrolment of the first patient in its multiple ascending doses (MAD)...Read more

Rentschler Biopharma to expand Japanese operation base

Clinical Research |  News | 0 Comment | 23 Oct, 2019

Germany based Rentschler Biopharma SE, a world-class contract development and manufacturing organization (CDMO) for biopharmaceuticals, hasreported that it will further enhance and develop ...Read more

ImaginAb inks pact with three global pharma companies

Clinical Research |  News | 0 Comment | 15 Oct, 2019

ImaginAb, Inc., a leading clinical-stage immuno-oncology imaging company has announced the signing of a multi-party collaboration agreement with AstraZeneca, Pfizer Inc. and Takeda Pharmace...Read more

Thermo Fisher expands clinical trials capabilities in China

Clinical Research |  News | 0 Comment | 26 Sep, 2019

Thermo Fisher Scientific, the world leader in serving science, announced an expansion of its integrated clinical trials supply and distribution services network, in Suzhou, China. To ...Read more

WCG KMR group invites Biopharma companies to enroll in Clinical Trial Cost Study

Clinical Research |  News | 0 Comment | 20 Sep, 2019

The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division announced on 17 Sep 2019 that the enrolment in WCG KMR Group’s 2019 Clinical Trial Cost Study is now ope...Read more

Japan's Solasia set to start trials for Darinaparsin

Clinical Research |  News | 0 Comment | 20 Sep, 2019

Solasia Pharma KK has  announced that the darinaparsin Phase 2 study patient registration has reached the target number of cases. The Phase 2 study was a multinational, single-gr...Read more

ASLAN presents Ph2 study data for Varlitinib tested on BTC patients

Clinical Research |  News | 0 Comment | 19 Sep, 2019

ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused biopharma company, on 19 Sep 2019 announced late-breaking top line data from a phase 2 study conducted in China testi...Read more

Covance unveils new R&D center in Shanghai

Clinical Research |  News | 0 Comment | 17 Sep, 2019

LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, has announced that its Covance Drug Development business celebrated the opening of its new...Read more

Novotech highlights South Korea's plans on clinical trials advancements

Clinical Research |  News | 0 Comment | 16 Sep, 2019

Asia-Pacific specialist CRO Novotech has welcomed the South Korean Comprehensive Five-year Plan for the Advancement of Clinical Trials aimed at further establishing the country as a leading...Read more

Strekin AG completes patient recruitment in RESTORE Ph3 of STR001

Clinical Research |  News | 0 Comment | 15 Sep, 2019

Strekin AG, a biopharmaceutical company focused on treatments for hearing loss, on 12 Sep 2019, announced that it has successfully completed patient recruitment in the RESTORE study, an int...Read more

IBI303 results for Ankylosing Spondylitis published in "The Lancet Rheumatology”

Clinical Research |  News | 0 Comment | 02 Sep, 2019

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high quality medicines, has announced that the clinical trial results of IBI303, an anti-t...Read more